Bayer has submitted an application for marketing authorization for its precision oncology treatment larotrectinib to the Ministry of Health, Labor and Welfare (MHLW) in Japan. Larotrectinib is an oral TRK inhibitor that has been developed specifically to treat adults and children
Industrial talks | 25/05/2020 | By Darshana | 535
Lupin's Pithampur Unit-1 facility receives EIR from U.S. FDA
Pharma major Lupin Limited (Lupin) today announced the receipt of the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (U.S. FDA) for its Pithampur Unit-1, India facility. The inspection for the facility was conducted by the U.S. FDA between February 3, 2020 and February 11, 2020
Industrial talks | 30/04/2020 | By Darshana | 491
Virtual Show: new technologies for solid dosage forms from Syntegon
From May 7 to 13, Syntegon Technology showcases its long-standing processing and packaging expertise for solid dosage forms at the Virtual Show. The new Sepion coater series, which is available in six sizes, marks the beginning of the novelties
Industrial talks | 29/04/2020 | By Darshana | 418
Bayer announced today its Canadian organization Bayer Inc., Mississauga, Ontario, will partner with the Population Health Research Institute (PHRI) in launching a major clinical research program aimed at identifying potential treatments against COVID-19
Industrial talks | 22/04/2020 | By Darshana | 306
FDA Approves First Therapy for Treatment of Low-Grade Upper Tract Urothelial Cancer
Today, the U.S. Food and Drug Administration approved Jelmyto (mitomycin gel), the first therapy to treat low-grade upper tract urothelial cancer (UTUC). Urothelial cancer is a cancer of the lining of the urinary system
Industrial talks | 16/04/2020 | By Darshana | 337
Corornavirus lockdown: Govt Orders Smooth Movement of Medial Equipments, Medicines
The central government has issued urgent orders to ensure smooth movement of medicines and other medical equipment in hospitals across the country which remains under a lockdown to contain the spread of novel coronavirus infection
Industrial talks | 28/03/2020 | By Darshana | 486
Insulin Gains New Pathway to Increased Competition: USA FDA
Today is a historic day and a landmark moment for patients with diabetes and other serious medical conditions, as insulin and certain other biologic drugs transition to a different regulatory pathway. This regulatory transition, mandated by Congress and implemented by the FDA, is incredibly important for patients
Industrial talks | 24/03/2020 | By Darshana | 562
CII Proposes Action Points For Strengthening Healthcare and Pharma Sectors Amidst Coronavirus Crisis
The Confederation of Indian Industry (CII) has proposed an action plan for strengthening the healthcare and pharmaceutical sectors to combat coronavirus crisis. The private sector can be a big support in government medical facilities, pharmaceuticals and medical equipment
Industrial talks | 21/03/2020 | By Darshana | 472
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy